Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Muscle Invasive Bladder Cancer × Chemoradiotherapy × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 7 Oropharyngeal Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 NSCLC 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1 Resectable Esophageal Cancer 1 Rectal Malignant Neoplasms 1 Radiation Injuries 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Cancer Non-resectable 1 Ototoxicity 1

Interventions

vistusertib 1 tislelizumab 1 olaparib 1 durvalumab 1 danvatirsen 1 adavosertib 1 Rutin 1 Neoadjuvant Therapy 1 Gemcitabine 1 Cystectomy 1 Cisplatin 1 AZD4547 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡